Compare BJ & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BJ | RDY |
|---|---|---|
| Founded | 1984 | 1984 |
| Country | United States | India |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 11.6B |
| IPO Year | 2018 | N/A |
| Metric | BJ | RDY |
|---|---|---|
| Price | $93.97 | $14.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 1 |
| Target Price | ★ $111.92 | $16.90 |
| AVG Volume (30 Days) | ★ 1.9M | 1.1M |
| Earning Date | 11-21-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 0.50% |
| EPS Growth | 4.02 | ★ 9.95 |
| EPS | ★ 4.34 | 0.79 |
| Revenue | ★ $21,160,412,000.00 | $3,851,623,984.00 |
| Revenue This Year | $7.62 | $6.12 |
| Revenue Next Year | $6.54 | $2.58 |
| P/E Ratio | $21.63 | ★ $17.83 |
| Revenue Growth | 2.82 | ★ 14.10 |
| 52 Week Low | $86.68 | $12.26 |
| 52 Week High | $121.10 | $16.17 |
| Indicator | BJ | RDY |
|---|---|---|
| Relative Strength Index (RSI) | 54.08 | 55.31 |
| Support Level | $92.89 | $14.03 |
| Resistance Level | $95.49 | $14.32 |
| Average True Range (ATR) | 2.19 | 0.17 |
| MACD | 0.24 | 0.02 |
| Stochastic Oscillator | 70.22 | 80.88 |
BJ's Wholesale serves as one of the few warehouse club chains in the United States. Its 250 warehouses are primarily located along the East Coast, most prominently in the New England area. Similar to its warehouse club peers, BJ's charges annual membership fees and keeps costs down by operating a "no-frills" store environment. The company limits the use of distribution centers where possible and stores inventory on pallets directly on the sales floor, often in bulk quantities. The company also offers a limited assortment of 7,000 stock-keeping units at its warehouses to achieve greater procurement scale on select items. About 80% of BJ's net sales come from grocery items and general merchandise, with the remaining 20% stemming from gasoline and other ancillary services.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.